(8α,10β,11β)-3-hydroxy-4,15-dinor-1(5)-xanthen-12,8-olide

Metabolite details

Identifier

MOXJTUNOIGNZKZ-UHFFFAOYSA-N

InChI Key

MOXJTUNOIGNZKZ-UHFFFAOYSA-N

IUPAC name

Preferred name

(8α,10β,11β)-3-hydroxy-4,15-dinor-1(5)-xanthen-12,8-olide

INN name

—

Synonym

6-(2-hydroxyethyl)-3,7-dimethyl-3,3a,4,7,8,8a-hexahydro-2H-cyclohepta[b]furan-2-one

ChEBI

CHEBI:138761

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Effects of MeJA on Arabidopsis metabolome under endogenous JA deficiency
• Effects of Radiofrequency Field from 5G Communications on fecal microbiome and metabolome profiles in mice
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_nsPEF_7_day
• WT_no_treatment_vs_opr3_8h
• Sham_vs_Radiofrequency
• Control_vs_CSD
• Control_vs_ZYP_High_Dose
• Control_0d_vs_Treatment_180d